President and CEO Rich Bendis sits down with industry leaders to talk about the forum and their views on the growth of the region.
In Part 1 his guests are John Trainer, VP and one of the partnering heads at AstraZeneca, Chris Frew, CEO of Workforce Genetics & President of BioBuzz Media, and Alex Philippidis, Senior Editor of Genetic Engineering & Biotechnology News.
In Part 2 his guests are Brian Darmody, CEO of AURP & Associate Vice President for Corporate Engagement at the University of Maryland and Vijay Ravindran CEO of 2019 Crab Trap Winner Floreo.
Were you unable to attend the 2019 BioHealth Capital Region Forum? Are you looking to stay updated on what is happening with Companies/Organizations/Institutions in the BHCR throughout the year? Be sure to bookmark http://www.biohealthcapital.com/ in your internet browsers today to keep yourself in the loop. From a look back at the Forum Agenda to News on Companies in the Region, the BHCR website is one of your go-to pages along with http://www.biohealthinnovation.org/.
Do you have news to share in the region? Be sure to let us know by tagging on social media! @BiohealthCR on Twitter. We can also be found on Facebook and LinkedIn!
Children’s National today announced a $30 million gift from the United Arab Emirates (UAE), marking a major milestone in the creation of its new Research & Innovation Campus. The gift will help drive pediatric discoveries that save and improve the lives of children in the Washington, D.C. region and around the world.
Are you excited about the work you do in the biohealth industry? How did you get to where you are? Would you like to be connected to the newest career ready talent pool?
Join us for a Happy Hour with post docs from NCI and other NIH institutes who have expressed interest in transitioning to our exciting industry! Help them learn about your work and opportunities in the field. You may find one of your best future hires in the process!
These events are being cohosted by BioHealth Innovation, American Gene Technologies and SciPhD. The events are free but registration is required.
The BioHealth Capital Region (BHCR) is rapidly becoming an industry hub for companies that are developing next-generation therapeutics that focus on personalized and regenerative medicine for the treatment and potential cure of unmet medical needs. Autolus, Inc., a CAR T-cell therapy company, and REGENXBIO, a gene therapy company focused therapies for rare diseases, are two examples of emerging leaders in the personalized medicine field making their imprint on the region.
Viela Bio today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) for the Company’s anti-CD19 monoclonal antibody inebilizumab, an investigational monotherapy for neuromyelitis optica spectrum disorder (NMOSD). NMOSD is a rare, life-threatening autoimmune disease affecting the central nervous system.
The Food and Drug Administration (FDA) on Friday announced that it granted final approval to the first generic naloxone hydrochloride nasal spray, which can be used to reverse opioid overdoses.
GlycoMimetics, Inc. (NASDAQ: GLYC) today announced the publication of a paper in Nature Cell Biology that describes how tumor cells engage specific stromal components, most notably E-selectin, for propagation and outgrowth.1 The paper provides further scientific support for the clinical trial in breast cancer patients with bone metastasis that was recently announced by GlycoMimetics.
The Golden State is living up to its nickname, with California ranking as the most innovative economy in America.
That’s according to Bloomberg’s newest U.S. State Innovation Index based on six equally-weighted metrics: research and development intensity, productivity, clusters of companies in technology, “STEM” jobs, populous with degrees in science and engineering disciplines, and patent activity.
If asked “What’s the most talent competitive city in the U.S.?” few Americans would name the top of our global list: Washington, D.C. (1). Often considered to be a (political) quagmire, the greater metropolitan area actually has a tremendous amount to offer. With an excellent environmental quality, major universities, an impressive number of physicians in the area and, of course, the presence of international global organisations, the greater Washington area provides a complete environment for talent competitiveness.
In honor of the new JLABS @ Washington, DC – a 32,000 square foot facility located on the new Children’s National Research and Innovation Campus from Johnson & Johnson Innovation, LLC in partnership with Children’s National Health System[1] (“Children’s National”) – Johnson & Johnson Innovation – JLABS announces the JLABS @ Washington, DC Children’s QuickFire Challenge.
Visionaries within the fields of pediatric oncology, pediatric surgery and influenza are invited to submit innovative ideas for a total of up to $150,000 in grant funding*; one year of residency at JLABS @ Washington, DC with the use of a bench, workstation, and access to the JLABS @ Washington, DC community; and mentorship from experts at the Johnson & Johnson Family of Companies.
Emergent BioSolutions Inc. (NYSE:EBS) today announced results from the interim analysis of its Phase 2 clinical study evaluating the safety and immunogenicity of the company’s chikungunya virus virus-like particle (CHIKV-VLP) vaccine candidate across a series of dosing regimens. The interim analysis has shown that with a single dose administered, up to 98% of study participants produced a neutralizing antibody response against the chikungunya virus (CHIKV) by Day 7. Further, the immune response was shown to be persistent through the six-month visit, including in the one-dose regimen.
It has four chambers, blood vessels and it beats — sort of.
In a first, scientists have 3D printed a heart using human tissue. Though the heart is much smaller than a human’s (it’s only the size of a rabbit’s), and there’s still a long way to go until it functions like a normal heart, the proof-of-concept experiment could eventually lead to personalized organs or tissues that could be used in the human body, according to a study published Monday (April 15) in the journal Advanced Science.
A nascent project launched by the Health and Human Services Department aims to spur innovation and help solve an expensive health crisis plaguing millions of Americans: kidney disease.
Developers hope it will one day be used as a model not only for introducing innovators to government, but for addressing other high-cost diseases.
Elon Musk’s tunneling startup, aptly-named The Boring Company, has taken a step towards its proposed loop system in the East Coast. In an announcement on Wednesday, the Transportation Department stated that the project had completed its environmental assessment, a draft of which will be available for public comment for the next 45 days.
